Bruce M. Wagman
Vice President, Regulatory Affairs, Quality Assurance, Pharmacovigilance, and Pharmaceutical Sciences
Mr. Wagman joined Prometheus in 2012 and manages the regulatory strategy, regulatory compliance, and Pharmacovigilance and Pharmaceutical Science operations for the development of prescription drugs, in-vitro diagnostics, and medical foods. Prior to joining Prometheus Laboratories, Mr. Wagman held positions of increasing managerial responsibility at Covance Inc., Omnicare Clinical Research, Genta Inc., MDS-Pharma, Inc., Astra USA, Inc., Bristol-Myers Squibb, Inc., Corning-PACT, Inc., Philadelphia Association of Clinical Trials (PACT) and served as Captain in the United States Air Force Nurse Corps culminating with an overseas tour of duty during operation Desert Storm in 1991. In June 2003, Mr. Wagman was awarded the Drug Information Association Outstanding Service Award. He has been on the DIA Annual Meeting Planning Committee as the Good Clinical Practices Track Chairperson for the 2008, 2009, 2010, 2011 DIA annual meetings. As a faculty member for the Drug Information Association, Bruce teaches the Regulatory Affairs I, IND Phase and Regulatory Affairs II, CTD/NDA Phase Course, Fundamentals of Clinical Research Monitoring Course and the Introduction to GCPs and Auditing Course. Mr. Wagman has provided Drug Development training for Pharmaceutical professionals and/or government officials located in Australia, Austria, Canada, China, Denmark, Germany, Israel, Jordan, Sweden and the United Kingdom. He is a current member of the Drug Information Association and the Regulatory Affairs Professionals Society. Mr. Wagman received a Bachelor of Science degree in Nursing from Syracuse University and his Master of Business Administration degree from Drexel University. He has been actively engaged in the Healthcare industry for thirty-one years, with eight years of experience managing patient care and twenty-three years in the Pharmaceutical industry.